BCG Vaccines Sales Market Estimated to Reach $65 million by 2025 - AJ Vaccines, China National, Greensignal, Intervax, Japan BCG, Merck, Sanofi, Serum, Statens Serum

BCG vaccines sales market was valued at $45 million in 2017, and is estimated to reach $65 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.

BCG vaccine is a live attenuated vaccine used for the prevention of tuberculosis. It is administered to newborns from tuberculosis and leprosy prevalent regions. This vaccine is generally administered to children at birth in countries with high incidence of TB. However, in low incidence regions, only children at high risk are typically immunized, whereas adults are generally not immunized. However, adults (up to the age of 35) who are frequently exposed to drug-resistant TB may also be given BCG vaccine.

Get Sample PDF For More Professional And Technical Insights at:
https://www.premiummarketinsights.com/sample/AMR00015540

Major factors that drive the market growth are increase in the prevalence of tuberculosis and rise in technological advancements in vaccine research. Moreover, increase in government initiatives and focus on immunization programs globally boost the market growth. However, side-effects and a global shortage of BCG vaccine restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.

This report segments the BCG vaccines sales market based on drug type, usage, end user, and region to provide a detailed assessment of the market. Based on drug type, it is bifurcated into immune BCG and therapy BCG. On the basis of usage, the market is categorized into tuberculosis and bladder cancer. Based on end user, it is segmented into adults and pediatrics. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the BCG vaccines sales market along with the current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
In-depth analysis of BCG vaccines sales based on drug type such as immune BCG and therapy BCG is carried out in the report.
The global BCG vaccines sales market scenario is comprehensively analyzed in accordance to the key cities.

Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00015540

Name: Sameer Joshi
Email: sales@premiummarketinsights.com
Organization: Premium Market Insights
Phone: +1-646-491-9876

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.

This release was published on openPR.